| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |